Follow
Shipra Rastogi
Shipra Rastogi
Medical Affairs
Verified email at ivey.ca
Title
Cited by
Cited by
Year
Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling
G Fusaro, P Dasgupta, S Rastogi, B Joshi, S Chellappan
Journal of Biological Chemistry 278 (48), 47853-47861, 2003
4482003
Nicotine induces cell proliferation, invasion and epithelial‐mesenchymal transition in a variety of human cancer cell lines
P Dasgupta, W Rizwani, S Pillai, R Kinkade, M Kovacs, S Rastogi, ...
International Journal of Cancer 124 (1), 36-45, 2009
4132009
Nicotine induces cell proliferation by β-arrestin–mediated activation of Src and Rb–Raf-1 pathways
P Dasgupta, S Rastogi, S Pillai, D Ordonez-Ercan, M Morris, E Haura, ...
The Journal of clinical investigation 116 (8), 2208-2217, 2006
3682006
Detection of aflatoxin M1 contamination in milk and infant milk products from Indian markets by ELISA
S Rastogi, PD Dwivedi, SK Khanna, M Das
Food control 15 (4), 287-290, 2004
3212004
Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines
S Rastogi, S Banerjee, S Chellappan, GR Simon
Cancer letters 257 (2), 244-251, 2007
1622007
Psychiatric adverse events during treatment with brodalumab: analysis of psoriasis clinical trials
MG Lebwohl, KA Papp, LB Marangell, J Koo, A Blauvelt, M Gooderham, ...
Journal of the American Academy of Dermatology 78 (1), 81-89. e5, 2018
1512018
Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells
AV Timoshenko, S Rastogi, PK Lala
British journal of cancer 97 (8), 1090-1098, 2007
1412007
Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes
S Rastogi, B Joshi, P Dasgupta, M Morris, K Wright, S Chellappan
Molecular and cellular biology 26 (11), 4161-4171, 2006
1172006
Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism
S Rastogi, B Joshi, G Fusaro, S Chellappan
Journal of Biological Chemistry 281 (5), 2951-2959, 2006
1062006
Protective effect of Ocimum sanctum on 3-methylcholanthrene, 7, 12-dimethylbenz (a) anthracene and aflatoxin B1 induced skin tumorigenesis in mice
S Rastogi, Y Shukla, BN Paul, DK Chowdhuri, SK Khanna, M Das
Toxicology and applied pharmacology 224 (3), 228-240, 2007
902007
TNF-α response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73
S Rastogi, W Rizwani, B Joshi, S Kunigal, SP Chellappan
Cell Death & Differentiation 19 (2), 274-283, 2012
862012
Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites
B Joshi, S Rastogi, M Morris, LM Carastro, C DeCook, E Seto, ...
Biochemical Journal 401 (1), 155-166, 2007
652007
Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate‐to‐severe plaque psoriasis: integrated analysis of the …
KA Papp, KB Gordon, RG Langley, MG Lebwohl, AB Gottlieb, S Rastogi, ...
British Journal of Dermatology 179 (2), 320-328, 2018
642018
Skin tumorigenic potential of aflatoxin B1 in mice
S Rastogi, RKS Dogra, SK Khanna, M Das
Food and chemical toxicology 44 (5), 670-677, 2006
582006
Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX
MI Niesen, AR Osborne, H Yang, S Rastogi, S Chellappan, JQ Cheng, ...
Journal of Biological Chemistry 280 (47), 38914-38922, 2005
552005
Direct binding of apoptosis signal-regulating kinase 1 to retinoblastoma protein: novel links between apoptotic signaling and cell cycle machinery
P Dasgupta, V Betts, S Rastogi, B Joshi, M Morris, B Brennan, ...
Journal of Biological Chemistry 279 (37), 38762-38769, 2004
532004
Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: a pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 …
A Blauvelt, KA Papp, MG Lebwohl, LJ Green, S Hsu, V Bhatt, S Rastogi, ...
Journal of the American Academy of Dermatology 77 (2), 372-374, 2017
492017
Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States
JJ Wu, SR Feldman, S Rastogi, B Menges, M Lingohr-Smith, J Lin
Journal of Dermatological Treatment 29 (8), 769-774, 2018
432018
A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light …
JSS Andreas Nikolis, Steven Bernstein, Brian Kinney, Nicolo Scuderi, Shipra ...
Clinical, Cosmetic and Investigational Dermatology 9, 115-125, 2016
352016
Efficacy and safety of brodalumab in patients with moderate-to-severe plaque psoriasis and skin of color: results from the pooled AMAGINE-2/-3 randomized trials
A McMichael, SR Desai, A Qureshi, S Rastogi, AF Alexis
American journal of clinical dermatology 20, 267-276, 2019
292019
The system can't perform the operation now. Try again later.
Articles 1–20